Crowdonomics
BIOCHAR LIFE

Reg CF · Revenue Share · Mar 2024

ClosedReached targetReg CFRevenue Share
via WeFunderView campaign
Raised
$173.2K / $350K max
49% of ceiling · target hit day 1
Investors
70
$2.5K avg
Valuation
—
—

Raised over time

Cumulative raisedInvestors
$173K$86K$0
67340
Mar 18, 2024 · openedJul 11, 2024 · last reading
Target ($100K) hit — Mar 19, 2024, day 1Deadline Apr 30, 2025 — 293 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via WeFunder; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2021–FY2022 · hover for source
$151K
−$48K
FY2021
FY2022
RevenueNet income
Metric
FY2021 reviewed
FY2022 reviewed
Income statement
Revenue
$150,952
—
Cost of goods sold
$152,293
—
Gross margin
-1%
—
Net income
-$48,407
—
Taxes paid
$0
—
Balance sheet
Cash
$55,639
—
Accounts receivable
$0
—
Total assets
$71,339
—
Short-term debt
$43,056
—
Long-term debt
$76,187
—
Total liabilities
$119,243
—
Other
Headcount
—
41

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. May 7, 2024
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Revenue share1%
Payout multiple2×

Offering details

Target$100,000
Max$350,000
Min investment$100
OpenedMar 18, 2024
DeadlineApr 30, 2025
ClosedJul 11, 2024
Days active115

Links & provenance

Source: Manual
0001670254-24-000228

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.